Barts Health NHS Trust


Klinik

Standort der Organisation:
London, Großbritannien (UK)


Publikationen in Kooperation mit FAU-Wissenschaftlerinnen und Wissenschaftlern


Fox, K., Achenbach, S., Bax, J., Cosyns, B., Delgado, V., Dweck, M.R.,... Popescu, B.A. (2019). Multimodality imaging in cardiology: a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging. European Heart Journal, 40(6), 553-558. https://dx.doi.org/10.1093/eurheartj/ehy669
Sidhu, B.S., Gould, J., Porter, B., Diemberger, I., Biffi, M., Seifert, M.,... Rinaldi, C.A. (2019). Patients Undergoing High-Risk CRT Upgrades with a WiSE-CRT System Have at Trend towards Improved Left Ventricular Remodelling Compared with Epicardial CRT Upgrades. In JOURNAL OF CARDIAC FAILURE (pp. S187-S187). Philadelphia, PA, US: PHILADELPHIA: CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS.
Tahir, H., Mease, P.J., Kavanaugh, A., Reimold, A., Rech, J., Hall, S.,... Mpofu, S. (2019). Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: final 5-year efficacy and safety results from the FUTURE 1 Phase 3 trial. In RHEUMATOLOGY (pp. 151-151). Birmingham, GB: OXFORD: OXFORD UNIV PRESS.
Sidhu, B.S., Gould, J., Porter, B., Turley, A., Diemberger, I., Biffi, M.,... Arnold, M. (2019). The WISE-CRT System Leads to Left Ventricular Remodeling and Improved Symptoms in Patients Who are Non-Responders to Epicardial CRT. In JOURNAL OF CARDIAC FAILURE (pp. S186-S186). Philadelphia, PA, US: PHILADELPHIA: CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS.
Sidhu, B.S., Gould, J., Porter, B., Diemberger, I., Biffi, M., Seifert, M.,... Arnold, M. (2019). The WiSE-CRT System Results in Left Ventricular Remodelling and Improved Symptoms in Patients Undergoing CRT Upgrades. In JOURNAL OF CARDIAC FAILURE (pp. S187-S188). Philadelphia, PA, US: PHILADELPHIA: CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS.
Bertog, S.C., Sobotka, N.A., Sobotka, P.A., Lobo, M.D., Sievert, K., Vaskelyte, L.,... Schmieder, R. (2018). Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension. Current Hypertension Reports, 20(3). https://dx.doi.org/10.1007/s11906-018-0816-8
Mease, P.J., Kavanaugh, A., Reimold, A., Tahir, H., Rech, J., Hall, S.,... Mpofu, S. (2018). Secukinumab Provides Sustained Improvements in the Signs and Symptoms in Psoriatic Arthritis: Final 5 Year Efficacy and Safety Results from a Phase 3 Trial.
Siegel, C.A., Lichtenstein, G., Siegmund, B., Lewis, J.D., Wolf, D., Louis, E.,... Dolin, P. (2017). Baseline characteristics of Crohn's disease patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (02). (pp. S333-S334).
Townsend, R.R., Mahfoud, F., Kandzari, D.E., Kario, K., Pocock, S., Weber, M.A.,... Böhm, M. (2017). Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. https://dx.doi.org/10.1016/S0140-6736(17)32281-X
Goode, E.L., Block, M.S., Kalli, K.R., Vierkant, R.A., Chen, W., Fogarty, Z.C.,... Ramus, S.J. (2017). Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. JAMA Oncology, 3(12). https://dx.doi.org/10.1001/jamaoncol.2017.3290
Mease, P.J., Kavanaugh, A., Reimold, A., Tahir, H., Rech, J., Hall, S.,... Mpofu, S. (2017). SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR EFFICACY AND SAFETY RESULTS FROM PHASE 3 FUTURE 1 TRIAL. (pp. 952-953).
Hall, S., Mease, P., Kavanaugh, A., Reimold, A., Tahir, H., Rech, J.,... Mpofu, S. (2017). SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS (PSA) THROUGH 3 YEARS: EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL. (pp. 37-38).
Kavanaugh, A., Mease, P., Reimold, A., Tahir, H., Rech, J., Hall, S.,... Mpofu, S. (2016). SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 2-YEAR EFFICACY AND SAFETY RESULTS FROM THE PHASE 3 RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, FUTURE 1. (pp. 598-598).
Mease, P.J., Kavanaugh, A., Reimold, A., Tahir, H., Rech, J., Hall, S.,... Mpofu, S. (2016). Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis through 3 Years: Efficacy and Safety Results from a Phase 3 Trial.
Nieman, K., Achenbach, S., Pugliese, F., Cosyns, B., Lancellotti, P., & Kitsiou, A. (2015). Cardiac computed tomography core syllabus of the European Association of Cardiovascular Imaging (EACVI). European Heart Journal Cardiovascular Imaging, 16(4), 351-2. https://dx.doi.org/10.1093/ehjci/jeu298

Zuletzt aktualisiert 2017-20-06 um 07:38